Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Ravn

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Vaccine|April 16, 2009
Poor control vaccines in two randomised trials of malaria vaccine?Peter Aaby, Henrik Ravn, Christine S Benn
The Pediatric Infectious Disease Journal|October 19, 2016
The WHO Review of the Possible Nonspecific Effects of Diphtheria-Tetanus-Pertussis VaccinePeter Aaby, Henrik Ravn, Christine S Benn
Lifetime Data Analysis|January 31, 2019
Modeling marginal features in studies of recurrent events in the presence of a terminal eventPer Kragh Andersen, Jules Angst, Henrik Ravn
Ebiomedicine|August 9, 2017
Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) Vaccinations May Reduce Infant Mortality More Than the WHO-schedule of BCG First and Then DTP. A Re-analysis of Demographic Surveillance Data From Rural BangladeshPeter Aaby, Andreas Andersen, Henrik Ravn, et al.
Statistical Methods in Medical Research|January 20, 2025
Efficient estimation of the marginal mean of recurrent events in randomized controlled trialsLuca Genetti, Giuliana Cortese, Henrik Ravn, et al.
International Journal of Epidemiology|February 16, 2008
Sex-differential non-specific effects of BCG and DTP in Cebu, The PhilippinesPeter Aaby, Christine Stabell Benn, Jens Nielsen, et al.
Statistics in Medicine|September 2, 2016
A marginal structural model for recurrent events in the presence of time-dependent confounding: non-specific effects of vaccines on child hospitalisationsAksel K G Jensen, Henrik Ravn, Signe Sørup, et al.
Pharmaceutical Statistics|September 8, 2021
Methodological challenges in the analysis of recurrent events for randomised controlled trials with application to cardiovascular events in LEADERJulie Kjaerulff Furberg, Søren Rasmussen, Per Kragh Andersen, et al.
Pharmaceutical Statistics|March 20, 2024
Simulation-based sample size calculations of marginal proportional means models for recurrent events with competing risksJulie Funch Furberg, Per Kragh Andersen, Thomas Scheike, et al.
JMIR Research Protocols|July 29, 2016
MHealth to Improve Measles Immunization in Guinea-Bissau: Study Protocol for a Randomized Controlled TrialEmil Rossing, Henrik Ravn, Celso Soares Pereira Batista, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Vaccine|April 16, 2009
Poor control vaccines in two randomised trials of malaria vaccine?Peter Aaby, Henrik Ravn, Christine S Benn
The Pediatric Infectious Disease Journal|October 19, 2016
The WHO Review of the Possible Nonspecific Effects of Diphtheria-Tetanus-Pertussis VaccinePeter Aaby, Henrik Ravn, Christine S Benn
Lifetime Data Analysis|January 31, 2019
Modeling marginal features in studies of recurrent events in the presence of a terminal eventPer Kragh Andersen, Jules Angst, Henrik Ravn
Ebiomedicine|August 9, 2017
Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) Vaccinations May Reduce Infant Mortality More Than the WHO-schedule of BCG First and Then DTP. A Re-analysis of Demographic Surveillance Data From Rural BangladeshPeter Aaby, Andreas Andersen, Henrik Ravn, et al.
Statistical Methods in Medical Research|January 20, 2025
Efficient estimation of the marginal mean of recurrent events in randomized controlled trialsLuca Genetti, Giuliana Cortese, Henrik Ravn, et al.
International Journal of Epidemiology|February 16, 2008
Sex-differential non-specific effects of BCG and DTP in Cebu, The PhilippinesPeter Aaby, Christine Stabell Benn, Jens Nielsen, et al.
Statistics in Medicine|September 2, 2016
A marginal structural model for recurrent events in the presence of time-dependent confounding: non-specific effects of vaccines on child hospitalisationsAksel K G Jensen, Henrik Ravn, Signe Sørup, et al.
Pharmaceutical Statistics|September 8, 2021
Methodological challenges in the analysis of recurrent events for randomised controlled trials with application to cardiovascular events in LEADERJulie Kjaerulff Furberg, Søren Rasmussen, Per Kragh Andersen, et al.
Pharmaceutical Statistics|March 20, 2024
Simulation-based sample size calculations of marginal proportional means models for recurrent events with competing risksJulie Funch Furberg, Per Kragh Andersen, Thomas Scheike, et al.
JMIR Research Protocols|July 29, 2016
MHealth to Improve Measles Immunization in Guinea-Bissau: Study Protocol for a Randomized Controlled TrialEmil Rossing, Henrik Ravn, Celso Soares Pereira Batista, et al.
Pageof 9